Rating: Strong Buy
Pfizer Financial Health
Profitability:8.4/10
✅ Pfizer has better Profitability than 77.78% of the companies on the Drug Manufacturers industry
Net Margin: 28.8%
✅ Pfizer has better Net Margin than 83.33% of the companies on the Drug Manufacturers industry
ROE (Return on Equity): 5.5%
✅ Pfizer has better ROE (Return on Equity) than 77.78% of the companies on the Drug Manufacturers industry
ROA (Return on Assets): 2.08%
✅ Pfizer has better ROA (Return on Assets) than 83.33% of the companies on the Drug Manufacturers industry
Operating Efficiency:10/10
✅ Pfizer has better Operating Efficiency than 83.33% of the companies on the Drug Manufacturers industry
Operating Margin: 139.45%
✅ Pfizer has better Operating Margin than 83.33% of the companies on the Drug Manufacturers industry
Liquidity:4.8/10
✅ Pfizer has better Liquidity than 66.67% of the companies on the Drug Manufacturers industry
Quick Ratio: 1.16
✅ Pfizer has better Quick Ratio than 66.67% of the companies on the Drug Manufacturers industry
Operating Cash Flow Ratio: 0.46
❌ Pfizer has worst Operating Cash Flow Ratio than 83.33% of the companies on the Drug Manufacturers industry
Solvency:6.14/10
❌ Pfizer has worst Solvency than 58.33% of the companies on the Drug Manufacturers industry
Debt to Equity Ratio: 0.99
❌ Pfizer has worst Debt to Equity Ratio than 66.67% of the companies on the Drug Manufacturers industry
Interest Coverage Ratio: 0.46
❌ Pfizer has worst Interest Coverage Ratio than 83.33% of the companies on the Drug Manufacturers industry